A comprehensive system to explore p53 mutations

被引:23
作者
Furuwatari, C
Yagi, A
Yamagami, O
Ishikawa, M
Hidaka, E
Ueno, I
Furihata, K
Ogiso, Y
Katsuyama, T
机构
[1] Shinshu Univ Hosp, Cent Clin Labs, Matsumoto, Nagano 390, Japan
[2] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 390, Japan
关键词
p53; mutations; polymerase chain reaction-single-strand conformation polymorphism; PCR-SSCP; fluorescence in situ hybridization; FISH; immunohistochemistry;
D O I
10.1093/ajcp/110.3.368
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To establish an effective and reliable system for the detection of p53 mutations, we evaluated the detection efficiencies of nonisotopic polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP), fluorescence in situ hybridization (FISH), and immunohistochemistry. Ten cell lines (AsPc1, BxPc3, Miapaca2, Pane1, Colo320-011, Love, MCF7, LNCaP, HL-60, and Daudi), a peripheral blood sample from a patient with a p53 germline mutation (p53GML), and a normal peripheral blood sample were used for examination. Direct nucleotide sequencing identified p53 mutations in 7 of 12 samples (AsPc1, BxPc3, Miapaca2, Pane1, Colo320-011, HL-60, and p53GML). The nonisotopic PCR-SSCP detected anomalies of the PCR fragments in 5 cell lines. In the FISH analysis, 2 cell lines exhibited loss of heterozygosity of the p53 locus. Immunohistochemistry detected an accumulation of the abnormal p53 in 4 cell lines. The combination of these 3 methods produced no false-negative or false-positive results. This combination may be an excellent and beneficial system for the clinical diagnosis of the various human cancers.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 11 条
[1]   EVALUATION OF 6 ANTIBODIES FOR IMMUNOHISTOCHEMISTRY OF MUTANT P53 GENE-PRODUCT IN ARCHIVAL COLORECTAL NEOPLASMS [J].
BAAS, IO ;
MULDER, JWR ;
OFFERHAUS, GJA ;
VOGELSTEIN, B ;
HAMILTON, SR .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :5-12
[2]   P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS [J].
DOHNER, H ;
FISCHER, K ;
BENTZ, M ;
HANSEN, K ;
BENNER, A ;
CABOT, G ;
DIEHL, D ;
SCHLENK, R ;
COY, J ;
STILGENBAUER, S ;
VOLKMANN, M ;
GALLE, PR ;
POUSTKA, A ;
HUNSTEIN, W ;
LICHTER, P .
BLOOD, 1995, 85 (06) :1580-1589
[3]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[4]  
Gomyo Y, 1996, INT J CANCER, V66, P594, DOI 10.1002/(SICI)1097-0215(19960529)66:5<594::AID-IJC2>3.0.CO
[5]  
2-O
[6]   GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS [J].
MALKIN, D ;
LI, FP ;
STRONG, LC ;
FRAUMENI, JF ;
NELSON, CE ;
KIM, DH ;
KASSEL, J ;
GRYKA, MA ;
BISCHOFF, FZ ;
TAINSKY, MA ;
FRIEND, SH .
SCIENCE, 1990, 250 (4985) :1233-1238
[7]  
MASHIYAMA S, 1991, ONCOGENE, V6, P1313
[8]  
MENDELSOHN J, 1995, MOL BASIS CANC, P94
[9]   NONRADIOACTIVE SINGLE-STRAND CONFORMATION POLYMORPHISM (SSCP) USING THE PHARMACIA PHASTSYSTEM [J].
MOHABEER, AJ ;
HITI, AL ;
MARTIN, WJ .
NUCLEIC ACIDS RESEARCH, 1991, 19 (11) :3154-3154
[10]   Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer [J].
Nguyen, DM ;
Spitz, FR ;
Yen, N ;
Cristiano, RJ ;
Roth, JA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (05) :1372-1376